Parkinson

• NGO / nonprofit
• Country: Australia

Smokers have a lower risk of Parkinson’s – we may have found out why

Why do smokers get Parkinson’s less often? New evidence from half a million adults in China points to carbon monoxide, not smoking itself.

• Country: Nepal

Why does Parkinson’s disease choose one side first?

Imagine noticing that one of your hands no longer moves quite as naturally as the other. Perhaps your fingers have become slower while buttoning a shirt, your handwriting has gradually become smaller, or one arm does not swing as freely when you walk. Later, a slight tremor may appear in the same…

• Country: Argentina

La curiosa manera en la que Alan Alda afronta las dificultades del Parkinson, a los 90 años: “Es como un pasatiempo”

El actor de M.A.S.H. y The West Wing reveló en una reciente entrevista cómo enfrenta los desafíos cotidianos que le presenta su enfermedad

• Country: United Kingdom

M-A-S-H star reveals strange sleep habit was first sign of Parkinson’s

• Country: United States

Alan Alda reveals unexpected weapon in his battle against Parkinson's disease

Alan Alda, now 90, reveals how humor and acceptance help him cope with Parkinson's disease, calling the condition "just a hobby" he lives with.

• Country: Nigeria

54-year-old Parkinson’s patient seeks N65m for brain surgery

A 54-year-old Nigerian, Aliyu Abdulmalik, who has drug-resistant Parkinson’s disease, is seeking public support to raise N65m for brain surgery in Turkey. Read More: https://punchng.com/54-year-old-parkinsons-patient-seeks-n65m-for-brain-surgery/

• Press releases
• Country: United States

Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value

First Patient Dosed with JOTROL ™ Marks Major Clinical Milestone for Jupiter Neurosciences’ Phase 2a Study Evaluating Safety, Pharmacokinetics and Biomarkers of JOTROL ™ in Patients with Parkinson’s Disease

• Press releases
• Country: United States

Parkinson's Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight

The Parkinson's disease market is expected to grow steadily, driven by the recent approval of AbbVie's JUVMO along with the rising prevalence of the disease, particularly among the aging population. Increasing disease awareness, improved diagnosis, and advances in symptomatic and...

• Press releases
• Country: United States

Cala Announces Nationwide Launch of its Next Generation TAPS Therapy Wearable for Essential Tremor and Parkinson's Disease Further Optimizing Meaningful Outcomes for More Patients

The Cala kIQ Plus System, cleared by FDA earlier this year, is the first and only wearable neuromodulation device for hand tremor that provides multiple therapy modes and adaptive calibration designed to optimize tremor relief and personalize treatment Cala is showcasing the Cala kIQ Plus...

• Press releases
• Country: United States

Lundbeck presents Phase Ib data for Lu AF28996 in advanced Parkinson's disease, as Phase II trial begins

Results from an 18-week, open-label Phase Ib trial of investigational Lu AF28996 in people with advanced Parkinson's disease are being presented at MDS 2026 The trial provided initial safety and tolerability data for Lu AF28996, with most treatment-emergent adverse events reported as mild...